One of the first indications concerning the role of PrPC in CSC biology dates back to the studies by Fan et al. [25,126], which provided strong evidence that over-expression of PrPC at both protein and mRNA levels occurs in gastric carcinomas and gastric cancer cell lines and correlates with increased invasive potential and therapeutic resistance. The gene discussed is PRNP; the disease is gastric cancer.